Growth Metrics

Catalyst Pharmaceuticals (CPRX) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 70.60%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 70.60%
Dec 31, 2025 3.83%
Sep 30, 2025 -7.74%
Jun 30, 2025 39.61%
Mar 31, 2025 92.04%
Dec 31, 2024 54.66%
Sep 30, 2024 49.71%
Jun 30, 2024 59.94%
Mar 31, 2024 121.92%
Dec 31, 2023 61.84%
Sep 30, 2023 57.88%
Jun 30, 2023 32.35%
Mar 31, 2023 18.48%
Dec 31, 2022 48.28%
Sep 30, 2022 36.43%
Jun 30, 2022 23.04%
Mar 31, 2022 45.13%
Dec 31, 2021 62.31%
Sep 30, 2021 72.15%
Jun 30, 2021 74.17%
Mar 31, 2021 35.31%
Dec 31, 2020 73.82%
Sep 30, 2020 85.17%
Jun 30, 2020 83.15%
Mar 31, 2020 56.86%
Dec 31, 2019 68.47%
Sep 30, 2019 90.94%
Jun 30, 2019 73.66%
Mar 31, 2019 -10.60%
Dec 31, 2018 -21.99%
Sep 30, 2018 -9.20%
Jun 30, 2018 -3.97%
Mar 31, 2018 -16.94%
Dec 31, 2017 -0.30%
Sep 30, 2017 9.62%
Jun 30, 2017 -2.22%
Mar 31, 2017 -16.67%
Dec 31, 2016 -2.28%
Sep 30, 2016 -24.86%
Jun 30, 2016 -33.83%
Mar 31, 2016 -37.96%
Dec 31, 2015 -41.37%
Sep 30, 2015 -69.46%
Jun 30, 2015 -54.74%
Mar 31, 2015 -42.79%
Dec 31, 2014 -40.50%
Sep 30, 2014 -41.73%
Jun 30, 2014 -27.00%
Mar 31, 2014 -43.23%
Dec 31, 2013 -75.11%
Sep 30, 2013 -27.25%